Media & Research

When it comes to Parkinson's disease, if we are only talking about “low dopamine levels”, then we are missing a very important part of the conversa...

  SYMBYX  Q&A session on light therapy, lead by you!  Panellists: Lakshi Vasudevan, SYMBYX Customer Care  Dr Katie McRae (DC), SYMBYX C...

This past Saturday, SYMBYX was featured in The Express UK; Parkinson’s (PD) is the world’s fastest growing neurodegenerative disease and second ...

A discussion on an integrated approach to managing Parkinson's with Special Guests and Panelists. Areas of Discussion: Navigating Dia...

      SYMBYX CEO, Dr Wayne Markman was hosted by Jessica Krauser and Brain Baker on their podcast series The Secret life of Parkinson's. The Secr...

      Description: Dr Roberta Chow, a world leading clinical practitioner and PhD in the field of laser therapy for pain management joined us ...

SYMBYX NEWS  Click here to read the latest SYMBYX news on light therapy. 1.  Rock 'n' Roll and Parkinson's. Q&A with former english musici...

     SYMBYX Webinar, 15th August. SYDNEY|TORONTO|DUBLIN. Wayne Markman, CEO of @SYMBYX Biome was joined by Orla Hares and Anita Saltmarche lead ...

   SYMBYX NEWS   Click here to read the latest SYMBYX news on light therapy. 1. Susie's Testimonial 2. SYMBYX in the Media 3. Lasers could help tre...

 Mater Research leads World-First Trial for Bowel Disease. 10 News Amanda Hart reports on the collaboration of Mater Research and SYMBYX, as they ...

Media release 2 June 2022 Mater Research leads world-first trial for bowel disease Mater Researchers are a step closer to discovering whether lase...